Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RESMED INCRMD · Entity 2692 | Global General Counsel | August 14, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RESMED INC
Report date August 14, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 12,718 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 3,230 · Balance 12,718 F1: Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Oct 2, 2026 00:23 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-26-000076 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,718 F1 · kind: Represents performance-based restricted stock units granted on November 20, 2025. The RSUs were earned on August 14, 2026, when the compensation and leadership development committee certified that the applicable performance metrics were met. RSUs vest 1/3 each year on the anniversary of the grant. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 19:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 268.742 | $190.57 | $51,214.16 |
DisclosureSEC source: 0000943819-26-000033 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,488 F1 · shares: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023. F2 · balance_after: Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 16:05 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 50 | $260.00 | $13,000.00 |
DisclosureSEC source: 0000943819-26-000009 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,691 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 18:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 50 | $241.75 | $12,087.50 |
DisclosureSEC source: 0000943819-26-000001 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,741 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:27 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 50 | $244.16 | $12,208.00 |
DisclosureSEC source: 0000943819-25-000185 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,791 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 500.735 | $250.10 | $125,233.82 |
DisclosureSEC source: 0000943819-25-000096 · form4.xml · nonDerivative · entry 4 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,841 F5 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 715.489 | $250.10 | $178,943.80 |
DisclosureSEC source: 0000943819-25-000096 · form4.xml · nonDerivative · entry 3 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,342 F4 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 173.725 | $250.10 | $43,448.62 |
DisclosureSEC source: 0000943819-25-000096 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,057 F3 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 19:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 135.075 | $250.10 | $33,782.26 |
DisclosureSEC source: 0000943819-25-000096 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,231 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. F2 · balance_after: Includes 38.9396 shares of ResMed stock purchased on October 31, 2025, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:32 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 100 | $274.36 | $27,436.00 |
DisclosureSEC source: 0000943819-25-000080 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,327 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 16:39 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020652 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,427 F1 · kind: Represents performance-based restricted stock units granted on November 20, 2024. The shares were earned on August 15, 2025, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 23:55 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 50 | $281.90 | $14,095.00 |
DisclosureSEC source: 0000943819-25-000030 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,486 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 19:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 66 | $256.99 | $16,961.34 |
DisclosureSEC source: 0000943819-25-000024 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,536 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 17:13 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 267.244 | $244.79 | $65,418.66 |
DisclosureSEC source: 0001127602-25-016359 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,603 F3 · shares: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 17:13 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 41 | $243.78 | $9,994.98 |
DisclosureSEC source: 0001127602-25-016359 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,870 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025. F2 · balance_after: Includes 64.6438 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 16:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 64 | $222.86 | $14,263.04 |
DisclosureSEC source: 0001127602-25-011320 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,846 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 64 | $234.10 | $14,982.40 |
DisclosureSEC source: 0001127602-25-007943 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,910 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 17:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 64 | $242.42 | $15,514.88 |
DisclosureSEC source: 0001127602-25-002880 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,974 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:52 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 75 | $230.99 | $17,324.25 |
DisclosureSEC source: 0001127602-25-000486 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,038 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| December 02, 2024 Filed Dec 2, 2024 23:02 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 74 | $248.91 | $18,419.34 |
DisclosureSEC source: 0001127602-24-028324 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,113 F2 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| November 29, 2024 Filed Dec 2, 2024 23:02 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-028324 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,187 F1 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Rider has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 136.837 | $252.38 | $34,534.92 |
DisclosureSEC source: 0001127602-24-027092 · form4.xml · nonDerivative · entry 4 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,360 F4 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 172.312 | $252.38 | $43,488.10 |
DisclosureSEC source: 0001127602-24-027092 · form4.xml · nonDerivative · entry 3 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,497 F3 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 134.303 | $252.38 | $33,895.39 |
DisclosureSEC source: 0001127602-24-027092 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,669 F2 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:45 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 684.979 | $252.38 | $172,875.00 |
DisclosureSEC source: 0001127602-24-027092 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,803 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:20 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 69 | $242.00 | $16,698.00 |
DisclosureSEC source: 0001127602-24-026442 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,443 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 18:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 882 | $231.00 | $203,742.00 |
DisclosureSEC source: 0001127602-24-022691 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,512 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted May 11, 2024. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 14:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 476 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022302 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,394 F2 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthegrant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 14:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022302 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,918 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest1/3each year on the anniversary of the grant. Read SEC document |
| June 04, 2024 Filed Jun 10, 2024 18:42 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 267.244 | $206.33 | $55,140.45 |
DisclosureSEC source: 0001127602-24-018237 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,444 F1 · shares: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023. F2 · balance_after: Includes 103.91 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| March 04, 2024 Filed Mar 7, 2024 01:46 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 81 | $180.00 | $14,580.00 |
DisclosureSEC source: 0001127602-24-008924 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,607 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:11 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 200 | $173.25 | $34,650.00 |
DisclosureSEC source: 0001127602-24-008301 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,688 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2023. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:33 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-028288 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,888 F1 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Rider has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:34 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 93.367 | $143.60 | $13,407.50 |
DisclosureSEC source: 0001127602-23-027469 · form4.xml · nonDerivative · entry 4 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,960 F4 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020. F5 · balance_after: Includes 41.402 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:34 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 136.592 | $143.60 | $19,614.61 |
DisclosureSEC source: 0001127602-23-027469 · form4.xml · nonDerivative · entry 3 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,054 F3 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/21/2019. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:34 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 117.573 | $143.60 | $16,883.48 |
DisclosureSEC source: 0001127602-23-027469 · form4.xml · nonDerivative · entry 2 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,190 F2 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:34 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 91.637 | $143.60 | $13,159.07 |
DisclosureSEC source: 0001127602-23-027469 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,308 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 01:29 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 25 | $143.42 | $3,585.50 |
DisclosureSEC source: 0001127602-23-026700 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,358 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 14:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 25 | $145.92 | $3,648.00 |
DisclosureSEC source: 0001127602-23-025408 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,383 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023. Read SEC document |
| September 01, 2023 Filed Sep 7, 2023 19:44 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 25 | $161.15 | $4,028.75 |
DisclosureSEC source: 0001127602-23-023838 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,408 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 17:09 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022933 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,433 F1 · kind: Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 21:30 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 25 | $224.12 | $5,603.00 |
DisclosureSEC source: 0001127602-23-021872 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,186 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023. Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 18:13 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 25 | $217.21 | $5,430.25 |
DisclosureSEC source: 0001127602-23-019888 · form4.xml · nonDerivative · entry 1 Rider Michael J · CIK 0001982205 · Global General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,211 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.